GlassScriptPhysician profile
Ekambaram Ilamathi
NPI 1326046715
$3,126.20
in general payments reported to CMS, 2019-2025
18 companies · $1,638 in 2025
The $1,638 reported for 2025 was more than what 87% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $121 · 2024: $1,242 · 2025: $1,638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,880.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $446.41 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $376.02 | 2024-2025 | Lokelma, Farxiga |
| Travere Therapeutics, INC. | $349.90 | 2024-2025 | Filspari |
| Amgen INC. | $307.03 | 2024-2025 | Krystexxa, Tavneos, Uplizna |
| Ardelyx, INC. | $228.96 | 2024-2025 | Ibsrela |
| Novartis Pharmaceuticals Corporation | $226.69 | 2024-2025 | |
| Novo Nordisk INC | $199.47 | 2025 | Ozempic |
| Lilly USA, LLC | $187.01 | 2024-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $146.53 | 2024-2025 | Jynarque |
| Vifor Pharma, INC. | $133.09 | 2024-2025 | Veltassa |
| Baxter Healthcare | $125.00 | 2019 | |
| Abbott Laboratories | $120.85 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.68 | 2024 | Jardiance |
| Takeda Pharmaceuticals U.S.A., INC. | $59.58 | 2024 | Gattex |
| Calliditas Therapeutics US INC. | $51.75 | 2025 | Tarpeyo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius USA Marketing, INC. | $25.08 | 2024 | Velphoro |
| Fresenius USA Manufacturing, INC. | $23.53 | 2025 | |
| Renalytix Ai, INC. | $22.62 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ekambaram Ilamathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.